サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/08/25 | 1,408 | 1,409 | 1,397 | 1,404 | +8 | +0.6% | 51,100 |
| 2017/08/24 | 1,391 | 1,405 | 1,376 | 1,396 | +6 | +0.4% | 81,800 |
| 2017/08/23 | 1,379 | 1,401 | 1,379 | 1,390 | +11 | +0.8% | 136,200 |
| 2017/08/22 | 1,375 | 1,387 | 1,362 | 1,379 | +19 | +1.4% | 81,600 |
| 2017/08/21 | 1,400 | 1,412 | 1,351 | 1,360 | -43 | -3.1% | 211,300 |
| 2017/08/18 | 1,390 | 1,410 | 1,389 | 1,403 | -26 | -1.8% | 124,300 |
| 2017/08/17 | 1,408 | 1,444 | 1,401 | 1,429 | +19 | +1.3% | 117,300 |
| 2017/08/16 | 1,385 | 1,423 | 1,379 | 1,410 | +27 | +2% | 104,900 |
| 2017/08/15 | 1,360 | 1,386 | 1,360 | 1,383 | +34 | +2.5% | 85,200 |
| 2017/08/14 | 1,350 | 1,364 | 1,332 | 1,349 | -30 | -2.2% | 146,700 |
| 2017/08/10 | 1,411 | 1,411 | 1,371 | 1,379 | -36 | -2.5% | 103,000 |
| 2017/08/09 | 1,418 | 1,420 | 1,370 | 1,415 | -7 | -0.5% | 222,000 |
| 2017/08/08 | 1,435 | 1,440 | 1,419 | 1,422 | -12 | -0.8% | 121,200 |
| 2017/08/07 | 1,433 | 1,449 | 1,426 | 1,434 | +29 | +2.1% | 189,000 |
| 2017/08/04 | 1,365 | 1,416 | 1,360 | 1,405 | +18 | +1.3% | 128,200 |
| 2017/08/03 | 1,403 | 1,416 | 1,382 | 1,387 | -29 | -2% | 163,500 |
| 2017/08/02 | 1,400 | 1,425 | 1,400 | 1,416 | +14 | +1% | 100,300 |
| 2017/08/01 | 1,448 | 1,448 | 1,398 | 1,402 | -46 | -3.2% | 247,900 |
| 2017/07/31 | 1,448 | 1,454 | 1,416 | 1,448 | -27 | -1.8% | 176,100 |
| 2017/07/28 | 1,494 | 1,495 | 1,460 | 1,475 | -22 | -1.5% | 159,200 |
| 2017/07/27 | 1,510 | 1,510 | 1,485 | 1,497 | -4 | -0.3% | 104,200 |
| 2017/07/26 | 1,495 | 1,515 | 1,472 | 1,501 | +11 | +0.7% | 125,300 |
| 2017/07/25 | 1,505 | 1,514 | 1,486 | 1,490 | -18 | -1.2% | 139,000 |
| 2017/07/24 | 1,511 | 1,528 | 1,505 | 1,508 | -18 | -1.2% | 89,100 |
| 2017/07/21 | 1,520 | 1,537 | 1,510 | 1,526 | ±0 | ±0% | 113,100 |
| 2017/07/20 | 1,540 | 1,543 | 1,520 | 1,526 | -18 | -1.2% | 143,200 |
| 2017/07/19 | 1,530 | 1,546 | 1,511 | 1,544 | +18 | +1.2% | 265,000 |
| 2017/07/18 | 1,492 | 1,527 | 1,477 | 1,526 | +48 | +3.2% | 309,200 |
| 2017/07/14 | 1,460 | 1,479 | 1,454 | 1,478 | +22 | +1.5% | 125,800 |
| 2017/07/13 | 1,458 | 1,488 | 1,452 | 1,456 | +8 | +0.6% | 147,300 |
| 2017/07/12 | 1,451 | 1,462 | 1,443 | 1,448 | -4 | -0.3% | 102,800 |
| 2017/07/11 | 1,445 | 1,476 | 1,440 | 1,452 | +7 | +0.5% | 189,900 |
| 2017/07/10 | 1,489 | 1,490 | 1,444 | 1,445 | -14 | -1% | 194,300 |
| 2017/07/07 | 1,490 | 1,496 | 1,440 | 1,459 | -50 | -3.3% | 451,900 |
| 2017/07/06 | 1,523 | 1,545 | 1,495 | 1,509 | -37 | -2.4% | 341,600 |
| 2017/07/05 | 1,505 | 1,546 | 1,470 | 1,546 | +62 | +4.2% | 531,700 |
| 2017/07/04 | 1,576 | 1,598 | 1,480 | 1,484 | -120 | -7.5% | 1,020,600 |
| 2017/07/03 | 1,600 | 1,694 | 1,575 | 1,604 | +201 | +14.3% | 3,534,600 |
| 2017/06/30 | 1,300 | 1,411 | 1,296 | 1,403 | +74 | +5.6% | 391,700 |
| 2017/06/29 | 1,305 | 1,329 | 1,261 | 1,329 | +8 | +0.6% | 203,300 |
| 2017/06/28 | 1,343 | 1,343 | 1,320 | 1,321 | -17 | -1.3% | 88,500 |
| 2017/06/27 | 1,341 | 1,348 | 1,323 | 1,338 | -9 | -0.7% | 96,500 |
| 2017/06/26 | 1,329 | 1,355 | 1,327 | 1,347 | +19 | +1.4% | 128,300 |
| 2017/06/23 | 1,363 | 1,383 | 1,322 | 1,328 | -35 | -2.6% | 209,800 |
| 2017/06/22 | 1,370 | 1,381 | 1,351 | 1,363 | -2 | -0.1% | 148,000 |
| 2017/06/21 | 1,331 | 1,371 | 1,312 | 1,365 | +28 | +2.1% | 284,100 |
| 2017/06/20 | 1,357 | 1,360 | 1,333 | 1,337 | -18 | -1.3% | 202,900 |
| 2017/06/19 | 1,358 | 1,362 | 1,325 | 1,355 | ±0 | ±0% | 210,000 |
| 2017/06/16 | 1,338 | 1,363 | 1,312 | 1,355 | +15 | +1.1% | 253,800 |
| 2017/06/15 | 1,291 | 1,342 | 1,289 | 1,340 | +20 | +1.5% | 319,600 |
1951～
2000
件表示中 / 2535件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 250,600円 | - | - | 0.00% | - | 116.07倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 151,600円 | +5.0% | +1.5% | 0.00% | 12.97倍 | 3.65倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
| 科研薬 | 386,600円 | -6.4% | -71.8% | 4.91% | 43.06倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 東和薬品 | 297,400円 | +7.9% | -3.3% | 2.69% | 8.27倍 | 0.85倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
